Skip to product information

ADCILIB 125MG CAP

Vendor: ADCILIB
Availability: In stock
Product type: Oncology
Composition: PALBOCILIB
Strength: 125MG
Dosage Form: Capsule

Prescription Required

Sale price  ₹ 3,900.00 Regular price  MRP: ₹ 7,837.50 50% OFF
Inclusive of all taxes.
ADCILIB 125MG CAP
Regular price ₹ 3,900.00
Regular price ₹ 7,837.50 Sale price ₹ 3,900.00 (-50%)
Strength: 125MG
Dosage Form: Capsule
ADCILIB 125MG CAP
ADCILIB 125MG CAP
Sale price  ₹ 3,900.00 Regular price  MRP: ₹ 7,837.50 50% OFF

Introduction

Adcilib 125mg Capsule contains palbociclib, a targeted CDK4/6 inhibitor that slows cancer-cell division by blocking proteins involved in cell-cycle progression.

Uses

  • Used with appropriate hormonal therapy for hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer.

Storage

  • Store at room temperature in a dry place.
  • Keep the capsules in the original packaging and away from children and pets.

Safety Information

  • Take exactly as prescribed, usually with food.
  • Regular blood tests are required because the medicine can lower blood-cell counts.
  • Inform the doctor about infection, liver disease, pregnancy, breastfeeding and all medicines.
  • Avoid grapefruit and St John’s wort.
  • Effective contraception is required.

Possible Side Effects

Possible side effects may include:

  • Low white blood-cell count, anaemia, low platelets, fatigue, nausea, diarrhoea, reduced appetite, hair thinning, mouth sores and increased creatinine.
  • Serious effects include severe infection, unusual bleeding and lung inflammation.

About RareMeds

We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.

The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.

No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.

Disclaimer

This information is for educational purposes only.

Adcilib is a prescription anticancer medicine and must be used under the supervision of an oncologist.

Do not change the treatment schedule without medical advice.

Related Products